newsfilter
← Latest News
GlobeNewswire·

Adagio Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference

WALTHAM, Mass., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Adagio Therapeutics, Inc., (NASDAQ:ADGI) a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of antibody-based solutions for infectious diseases with p